WILMINGTON, DE — NiKang Therapeutics® Inc. has achieved a pivotal step in the development of its first-in-class CDK2 degrader ...
Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) is expected to post its quarterly earnings results before the market opens on Tuesday, March 18th. Analysts expect Cyclacel Pharmaceuticals to ...
StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Saturday morning. The firm issued a buy rating on the stock. MEI Pharma Price Performance MEIP ...
Beigene Switzerland GmbH has divulged CDK2/cyclin E1 inhibitors reported to be useful for the treatment of cancer.
Background Recent meta-analyses suggested diclofenac may be superior to indomethacin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). The aim of our study ...
After hours: March 21 at 7:50:01 PM EDT Loading Chart for NVS ...
Pre-Market: 8:04:50 a.m. EDT Loading Chart for NVS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback